Id |
Subject |
Object |
Predicate |
Lexical cue |
T138 |
0-51 |
Sentence |
denotes |
Table 2 Current and emerging technologies in asthma |
T139 |
52-107 |
Sentence |
denotes |
Technology Measures Outcomes in asthma studies Comments |
T140 |
108-127 |
Sentence |
denotes |
Wearable technology |
T141 |
128-137 |
Sentence |
denotes |
− Fitbit™ |
T142 |
138-318 |
Sentence |
denotes |
− Apple™ Watch Fitbit: heart rate (available on most but not all models), steps/day, physical activity (light, moderate and vigorous), sedentary time, sleep efficiency, wake counts |
T143 |
319-523 |
Sentence |
denotes |
Apple Watch: heart rate, EKG, steps/day, physical activity (light, moderate and vigorous), sedentary time − Fitbit overestimated sleep efficiency and underestimated wake counts compared with actigraphy.18 |
T144 |
524-630 |
Sentence |
denotes |
− Fitbit-derived sleep quality correlated with PROMIS pediatric asthma impact score.21 Corresponding Apps: |
T145 |
631-690 |
Sentence |
denotes |
Apple Watch App on iPhone, Fitbit App on iPhone and Android |
T146 |
691-868 |
Sentence |
denotes |
Pros: portable; commercially available; may be useful when used with other measures such as air quality, lung function and asthma symptoms to digitally phenotype asthma patients |
T147 |
869-874 |
Sentence |
denotes |
Cons: |
T148 |
875-935 |
Sentence |
denotes |
No sleep data available on Apple Watch without 3rd party App |
T149 |
936-949 |
Sentence |
denotes |
Data sharing: |
T150 |
950-1076 |
Sentence |
denotes |
Data does not sync to EMR directly but patient can access file and send to provider via mail, secure email, or patient portal. |
T151 |
1077-1168 |
Sentence |
denotes |
Electronic monitoring devices (e.g., inhaler sensors ± digital health platform) Digihaler™: |
T152 |
1169-1280 |
Sentence |
denotes |
− Inhaler time of inhaler use, peak inspiratory flow rate (PIFR), time to PIFR, inhalation volume and duration. |
T153 |
1281-1305 |
Sentence |
denotes |
Propeller Health System: |
T154 |
1306-1360 |
Sentence |
denotes |
− Inhaler sensor: date, time and number of doses taken |
T155 |
1361-1390 |
Sentence |
denotes |
− Asthma Health Platform App: |
T156 |
1391-1516 |
Sentence |
denotes |
Location of inhaler use using phone GPS, current weather/pollen counts/air pollution and self-report asthma symptoms/triggers |
T157 |
1517-1534 |
Sentence |
denotes |
Hailie™ solution: |
T158 |
1535-1610 |
Sentence |
denotes |
− Inhaler sensor: date, time, number of inhaler actuations and missed doses |
T159 |
1611-1674 |
Sentence |
denotes |
− Hailie™ App: medication adherence, daily medication reminders |
T160 |
1675-1712 |
Sentence |
denotes |
Inhaler compliance assessment device: |
T161 |
1713-1808 |
Sentence |
denotes |
Time of dose, inhaler technique errors − Greater asthma control31,38–39 and symptom-free days33 |
T162 |
1809-1898 |
Sentence |
denotes |
− Reduction in daily symptoms31, rescue medication use29,32–33, and exacerbations34,38–39 |
T163 |
1899-1935 |
Sentence |
denotes |
− Improved medication adherence36–40 |
T164 |
1936-2008 |
Sentence |
denotes |
− High patient acceptability of device and digital health platform36–37. |
T165 |
2009-2028 |
Sentence |
denotes |
Corresponding Apps: |
T166 |
2029-2067 |
Sentence |
denotes |
Digihaler™, Propeller Health, Hailie™. |
T167 |
2068-2141 |
Sentence |
denotes |
Web-based platform also available for Propeller Health, Hailie™ solution. |
T168 |
2142-2307 |
Sentence |
denotes |
Pros: portable, high acceptability among patients, improvements in asthma control in those with a digital health platform (e.g., Propeller Health, Hailie™ solution). |
T169 |
2308-2313 |
Sentence |
denotes |
Cons: |
T170 |
2314-2434 |
Sentence |
denotes |
Additional efficacy studies of the devices are needed, cost of devices are not always covered by insurance reimbursement |
T171 |
2435-2448 |
Sentence |
denotes |
Data sharing: |
T172 |
2449-2609 |
Sentence |
denotes |
Provider platform available to share results (e.g. Digihaler™, Propeller Health, Hailie™ solution), patients may share data from Digihaler™ also via file share. |
T173 |
2610-2655 |
Sentence |
denotes |
Mobile-based applications Self-monitoring of: |
T174 |
2656-2673 |
Sentence |
denotes |
− Asthma symptoms |
T175 |
2674-2684 |
Sentence |
denotes |
− Triggers |
T176 |
2685-2763 |
Sentence |
denotes |
− Medication use -Improvements in asthma control though low-quality evidence45 |
T177 |
2764-2886 |
Sentence |
denotes |
-Improvements in asthma control in five studies, lung function in two studies and quality of life in three studies46 Pros: |
T178 |
2887-2917 |
Sentence |
denotes |
Acceptable and feasible to use |
T179 |
2918-2923 |
Sentence |
denotes |
Cons: |
T180 |
2924-3045 |
Sentence |
denotes |
Vary in quality; data are self-reported, most apps have not been validated; risk of loss of privacy of health information |
T181 |
3046-3059 |
Sentence |
denotes |
Data sharing: |
T182 |
3060-3142 |
Sentence |
denotes |
Vary in ability to share with provider, most are up to user to share with provider |